1. Home
  2. FIHL vs LGND Comparison

FIHL vs LGND Comparison

Compare FIHL & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIHL
  • LGND
  • Stock Information
  • Founded
  • FIHL 2014
  • LGND 1987
  • Country
  • FIHL Bermuda
  • LGND United States
  • Employees
  • FIHL N/A
  • LGND N/A
  • Industry
  • FIHL
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • FIHL
  • LGND Health Care
  • Exchange
  • FIHL Nasdaq
  • LGND Nasdaq
  • Market Cap
  • FIHL 1.8B
  • LGND 2.1B
  • IPO Year
  • FIHL 2023
  • LGND 1992
  • Fundamental
  • Price
  • FIHL $17.00
  • LGND $104.48
  • Analyst Decision
  • FIHL Hold
  • LGND Strong Buy
  • Analyst Count
  • FIHL 7
  • LGND 8
  • Target Price
  • FIHL $19.71
  • LGND $144.71
  • AVG Volume (30 Days)
  • FIHL 454.8K
  • LGND 104.5K
  • Earning Date
  • FIHL 05-14-2025
  • LGND 05-08-2025
  • Dividend Yield
  • FIHL 2.35%
  • LGND N/A
  • EPS Growth
  • FIHL N/A
  • LGND N/A
  • EPS
  • FIHL 0.98
  • LGND N/A
  • Revenue
  • FIHL $2,420,000,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • FIHL $20.33
  • LGND $16.47
  • Revenue Next Year
  • FIHL $9.13
  • LGND $19.44
  • P/E Ratio
  • FIHL $17.37
  • LGND N/A
  • Revenue Growth
  • FIHL 23.65
  • LGND 53.40
  • 52 Week Low
  • FIHL $14.17
  • LGND $72.61
  • 52 Week High
  • FIHL $21.32
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • FIHL 62.21
  • LGND 46.11
  • Support Level
  • FIHL $16.59
  • LGND $99.24
  • Resistance Level
  • FIHL $16.55
  • LGND $107.37
  • Average True Range (ATR)
  • FIHL 0.34
  • LGND 4.05
  • MACD
  • FIHL 0.05
  • LGND -0.33
  • Stochastic Oscillator
  • FIHL 96.88
  • LGND 39.37

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: